Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

PharmaLundensis

Less than 1K followers
Overview
Investor views
All
Press releases
ShowingAll content types

Press release2026-07-03 11:10

Sista chansen att följa med på PharmaLundensis resa

PharmaLundensis
Press release2026-07-01 14:38

PharmaLundensis: Information kring bolagets finansieringsstrategi

PharmaLundensis
Press release2026-06-30 14:48

PharmaLundensis: Phal-501 binder tungmetaller mycket effektivare än IodoCarb

PharmaLundensis

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-06-30 14:07

PharmaLundensis: Frivillig avnotering har godkänts, sista dag för handel blir 14 juli

PharmaLundensis
Press release2026-06-29 16:16

PharmaLundensis: Komplettering till Information om kommande företrädesemission

PharmaLundensis
Press release2026-06-29 13:49

PharmaLundensis: Information om kommande företrädesemission

PharmaLundensis
Press release2026-06-25 18:16

PharmaLundensis: Kommuniké från årsstämma

PharmaLundensis
Press release2026-06-04 14:07

PharmaLundensis: Komplettering till Årsredovisning för 2025

PharmaLundensis
Regulatory press release2026-06-04 13:05

Årsredovisning för PharmaLundensis AB (publ) 556708-8074 Räkenskapsåret 2025-01-01 - 2025-12-31

PharmaLundensis
Regulatory press release2026-05-28 16:10

PharmaLundensis: Kvartalsrapport 2026-01-01 till 2026-03-31

PharmaLundensis
Press release2026-05-21 21:02

Kallelse till årsstämma i PharmaLundensis AB

PharmaLundensis
Press release2026-05-20 10:03

PharmaLundensis: Senarelägger Q1 rapport till torsdag den 28 Maj

PharmaLundensis
Press release2026-04-20 12:23

PharmaLundensis: Tidsplan för frivillig avnotering av aktie från Spotlight

PharmaLundensis
Press release2026-04-17 17:27

PharmaLundensis: Vidare information kring avnotering av aktie från Spotlight

PharmaLundensis
Press release2026-03-30 19:58

PharmaLundensis: Publicering av uppdaterad Internationell Affärsplan

PharmaLundensis
Press release2026-03-30 10:49

PharmaLundensis: Huvudägare kommer föreslå avnotering av aktie från Spotlight

PharmaLundensis
Press release2026-03-17 15:45

PharmaLundensis: Presenterar internationell Affärsplan

PharmaLundensis
Press release2026-03-17 13:42

PharmaLundensis: Registrering av företrädesemission hos Bolagsverket klar

PharmaLundensis
Regulatory press release2026-02-23 16:38

PharmaLundensis: Nyemission tecknades för ca 2,14 miljoner kronor

PharmaLundensis
Press release2026-02-05 14:27

PharmaLundensis: Publicering av emissionshandlingar och start av teckningstid

PharmaLundensis